
Opinion|Videos|August 15, 2024
Topical Ruxolitinib in Vitiligo: Real-World Experiences and Cultural Considerations
Author(s)Chesahna Kindred, MD, MBA, FAAD
Chesahna Kindred, MD, discusses real-world experiences and cultural considerations associated with topical ruxolitinib for the treatment of vitiligo.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Dermatology Times
1
AbbVie Completes $10.9 Billion Apogee Acquisition, Adds Zumilokibart to AD Pipeline
2
Uncovering the Autoimmune Links & Systemic Impact of Chronic Spontaneous Urticaria
3
10 Skin Cancer Exam Tips
4
Dermatology Times Conferences & Meetings Calendar: September 2026
5






